276 related articles for article (PubMed ID: 9537257)
41. Identification and temporal expression pattern of genes modulated during irreversible growth arrest and terminal differentiation in human melanoma cells.
Huang F; Adelman J; Jiang H; Goldstein NI; Fisher PB
Oncogene; 1999 Jun; 18(23):3546-52. PubMed ID: 10376533
[TBL] [Abstract][Full Text] [Related]
42. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
43. Correlation between post-replication repair and metastatic potential in B16 mouse melanoma cell lines.
Khalil F; Hopp L
Cytobios; 1985; 42(166):117-23. PubMed ID: 3996045
[TBL] [Abstract][Full Text] [Related]
44. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis.
Alonso SR; Tracey L; Ortiz P; Pérez-Gómez B; Palacios J; Pollán M; Linares J; Serrano S; Sáez-Castillo AI; Sánchez L; Pajares R; Sánchez-Aguilera A; Artiga MJ; Piris MA; Rodríguez-Peralto JL
Cancer Res; 2007 Apr; 67(7):3450-60. PubMed ID: 17409456
[TBL] [Abstract][Full Text] [Related]
45. Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo.
Suryo Rahmanto Y; Dunn LL; Richardson DR
Carcinogenesis; 2007 Oct; 28(10):2172-83. PubMed ID: 17449903
[TBL] [Abstract][Full Text] [Related]
46. Analysis of APAF-1 expression in human cutaneous melanoma progression.
Baldi A; Santini D; Russo P; Catricalà C; Amantea A; Picardo M; Tatangelo F; Botti G; Dragonetti E; Murace R; Tonini G; Natali PG; Baldi F; Paggi MG
Exp Dermatol; 2004 Feb; 13(2):93-7. PubMed ID: 15009102
[TBL] [Abstract][Full Text] [Related]
47. cDNA-array profiling of melanomas and paired melanocyte cultures.
Mischiati C; Natali PG; Sereni A; Sibilio L; Giorda E; Cappellacci S; Nicotra MR; Mariani G; Di Filippo F; Catricalà C; Gambari R; Grammatico P; Giacomini P
J Cell Physiol; 2006 Jun; 207(3):697-705. PubMed ID: 16523488
[TBL] [Abstract][Full Text] [Related]
48. Expression of the heat shock cognate protein HSP73 correlates with tumour thickness of primary melanomas and is enhanced in melanoma metastases.
Deichmann M; Polychronidis M; Benner A; Kleist C; Thome M; Kahle B; Helmke BM
Int J Oncol; 2004 Aug; 25(2):259-68. PubMed ID: 15254721
[TBL] [Abstract][Full Text] [Related]
49. Spontaneous sister chromatid exchange in metastatic variants of the murine B16 melanoma and human astrocytomas in culture.
Lakshmi MS; Hunt G; Sherbet GV
Invasion Metastasis; 1988; 8(4):205-16. PubMed ID: 3139579
[TBL] [Abstract][Full Text] [Related]
50. Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP.
Goldberg SF; Miele ME; Hatta N; Takata M; Paquette-Straub C; Freedman LP; Welch DR
Cancer Res; 2003 Jan; 63(2):432-40. PubMed ID: 12543799
[TBL] [Abstract][Full Text] [Related]
51. Characterization of multiple cathepsin B mRNAs in murine B16a melanoma.
Qian F; Frankfater A; Steiner DF; Bajkowski AS; Chan SJ
Anticancer Res; 1991; 11(4):1445-51. PubMed ID: 1746902
[TBL] [Abstract][Full Text] [Related]
52. Biophysical identification and sorting of high metastatic variants from B16 melanoma tumor.
Lessin SR; Abraham SR; Nicolini C
Cytometry; 1982 May; 2(6):407-13. PubMed ID: 7075401
[TBL] [Abstract][Full Text] [Related]
53. Rate of generation of major karyotypic abnormalities in relationship to the metastatic potential of B16 murine melanoma.
Kendal WS; Wang RY; Hsu TC; Frost P
Cancer Res; 1987 Jul; 47(14):3835-41. PubMed ID: 3594440
[TBL] [Abstract][Full Text] [Related]
54. Melastatin expression and prognosis in cutaneous malignant melanoma.
Duncan LM; Deeds J; Cronin FE; Donovan M; Sober AJ; Kauffman M; McCarthy JJ
J Clin Oncol; 2001 Jan; 19(2):568-76. PubMed ID: 11208852
[TBL] [Abstract][Full Text] [Related]
55. Differential cell- and immuno-biological properties of murine B16-F1 and F10 melanomas: oncogene c-fos expression, sensitivity to LAK cells and/or IL-2, and components of gangliosides.
Nakayama J; Urabe K; Tsuchida T; Urabe A; Terao H; Taniguchi S; Hori Y
J Dermatol; 1995 Aug; 22(8):549-59. PubMed ID: 7560451
[TBL] [Abstract][Full Text] [Related]
56. Heterogeneity of protein phosphorylation in metastatic variants of B16 melanoma.
Greig RG; Caltabiano L; Reid R; Feild J; Poste G
Cancer Res; 1983 Dec; 43(12 Pt 1):6057-65. PubMed ID: 6640547
[TBL] [Abstract][Full Text] [Related]
57. Expression of the fos oncogene in B16 melanoma cells exhibiting different metastatic abilities.
Urabe A; Nakayama J; Taniguchi S; Inoue M; Hori Y
J Dermatol Sci; 1990 Nov; 1(6):455-8. PubMed ID: 2126954
[TBL] [Abstract][Full Text] [Related]
58. Down-regulation of ras and myc expression associated with mdr-1 overexpression in adriamycin-resistant tumor cells.
Banerjee S; Ganapathi R; Ghosh L; Yu CL
Cell Mol Biol; 1992 Sep; 38(6):561-70. PubMed ID: 1363885
[TBL] [Abstract][Full Text] [Related]
59. Structure, expression and chromosome mapping of MLZE, a novel gene which is preferentially expressed in metastatic melanoma cells.
Watabe K; Ito A; Asada H; Endo Y; Kobayashi T; Nakamoto K; Itami S; Takao S; Shinomura Y; Aikou T; Yoshikawa K; Matsuzawa Y; Kitamura Y; Nojima H
Jpn J Cancer Res; 2001 Feb; 92(2):140-51. PubMed ID: 11223543
[TBL] [Abstract][Full Text] [Related]
60. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene.
Kim M; Gans JD; Nogueira C; Wang A; Paik JH; Feng B; Brennan C; Hahn WC; Cordon-Cardo C; Wagner SN; Flotte TJ; Duncan LM; Granter SR; Chin L
Cell; 2006 Jun; 125(7):1269-81. PubMed ID: 16814714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
